Brief: Corvus Pharmaceuticals Says Trial To Enroll Patients At 40 Sites In US, Canada, Australia, South Korea

Corvus Pharmaceuticals

10/09/2024 16:28

Sept 10 (Reuters) - Corvus Pharmaceuticals Inc  CRVS.O :
    * CORVUS PHARMACEUTICALS INITIATES REGISTRATIONAL PHASE 3
CLINICAL
TRIAL OF SOQUELITINIB FOR PATIENTS WITH RELAPSED/REFRACTORY
PERIPHERAL T-CELL LYMPHOMA
    * CORVUS PHARMACEUTICALS INC - TRIAL TO ENROLL PATIENTS AT
40
SITES IN US, CANADA, AUSTRALIA, SOUTH KOREA

Source text for Eikon:  ID:nGNXbdznfP 
Further company coverage:  CRVS.O 

 ((Reuters.Briefs@thomsonreuters.com;))